{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:22:14Z","timestamp":1789770134404,"version":"4.0.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["No. ZR2023QH507"],"award-info":[{"award-number":["No. ZR2023QH507"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2025MS1262"],"award-info":[{"award-number":["ZR2025MS1262"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82573211"],"award-info":[{"award-number":["No. 82573211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special Foundation for Taishan Scholars","award":["No. tstp20250509"],"award-info":[{"award-number":["No. tstp20250509"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02627-4","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:04:57Z","timestamp":1773187497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CircNSD2 promotes metastasis and immune escape by increasing the USP10\/SRSF6-mediated alternative splicing of TPM1 in TNBC"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuhan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinqiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"3","key":"2627_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2627_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2627_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","volume":"8","author":"P Zagami","year":"2022","unstructured":"Zagami P, Carey LA. Triple negative breast cancer: pitfalls and progress. NPJ Breast Cancer. 2022;8(1):95.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"2627_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang H, Merkher Y, Chen L, Liu N, Leonov S, et al. Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol. 2022;15(1):121.","journal-title":"J Hematol Oncol"},{"key":"2627_CR5","doi-asserted-by":"crossref","unstructured":"Pajewska M, Partyka O, Czerw A, Depta\u0142a A, Sygit K, G\u0105ska I, et al. Advanced and metastatic triple negative breast cancer-potential new treatment. Cancers. 2025;17(7):1183.","DOI":"10.3390\/cancers17071183"},{"issue":"1","key":"2627_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-023-01850-7","volume":"22","author":"Y Liu","year":"2023","unstructured":"Liu Y, Hu Y, Xue J, Li J, Yi J, Bu J, et al. Advances in immunotherapy for triple-negative breast cancer. Mol Cancer. 2023;22(1):145.","journal-title":"Mol Cancer"},{"issue":"1","key":"2627_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, et al. TGF-beta signaling in health, disease, and therapeutics. Signal Transduct Target Ther. 2024;9(1):61.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2627_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13045-022-01349-6","volume":"15","author":"X Shi","year":"2022","unstructured":"Shi X, Yang J, Deng S, Xu H, Wu D, Zeng Q, et al. TGF-beta signaling in the tumor metabolic microenvironment and targeted therapies. J Hematol Oncol. 2022;15(1):135.","journal-title":"J Hematol Oncol"},{"key":"2627_CR9","doi-asserted-by":"crossref","unstructured":"Hao Y, Baker D, Ten Dijke P. TGF-beta-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci. 2019;20(11):2767.","DOI":"10.3390\/ijms20112767"},{"issue":"1","key":"2627_CR10","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41467-022-28492-5","volume":"13","author":"X Xia","year":"2022","unstructured":"Xia X, Zhang Z, Zhu C, Ni B, Wang S, Yang S, et al. Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications. Nat Commun. 2022;13(1):1017.","journal-title":"Nat Commun"},{"issue":"2","key":"2627_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cac2.12130","volume":"41","author":"S Li","year":"2021","unstructured":"Li S, Zhang J, Qian S, Wu X, Sun L, Ling T, et al. S100A8 promotes epithelial-mesenchymal transition and metastasis under TGF-beta\/USF2 axis in colorectal cancer. Cancer Commun (Lond). 2021;41(2):154\u201370.","journal-title":"Cancer Commun (Lond)"},{"issue":"3","key":"2627_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/1878-0261.12162","volume":"12","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Ma J, Fan Y, Wang Z, Tian R, Ji W, et al. TGF-beta transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK\/Sp1 signaling pathways. Mol Oncol. 2018;12(3):305\u201321.","journal-title":"Mol Oncol"},{"issue":"5","key":"2627_CR13","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.celrep.2018.04.007","volume":"23","author":"EN Arwert","year":"2018","unstructured":"Arwert EN, Harney AS, Entenberg D, Wang Y, Sahai E, Pollard JW, et al. A unidirectional transition from migratory to perivascular macrophage is required for tumor cell intravasation. Cell Rep. 2018;23(5):1239\u201348.","journal-title":"Cell Rep"},{"issue":"1","key":"2627_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2021","unstructured":"Derynck R, Turley SJ, Akhurst RJ. TGFbeta biology in cancer progression and immunotherapy. Nat Rev Clin Oncol. 2021;18(1):9\u201334.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"2627_CR15","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.21037\/tcr-22-292","volume":"11","author":"Z Li","year":"2022","unstructured":"Li Z, Wang F, Dang J, Cheng F, Zheng F. Bidirectional regulation between tumor cell-intrinsic PD-L1 and TGF-beta1 in epithelial-to-mesenchymal transition in melanoma. Transl Cancer Res. 2022;11(10):3698\u2013710.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"2627_CR16","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1038\/s41467-022-31250-2","volume":"13","author":"F Xie","year":"2022","unstructured":"Xie F, Zhou X, Su P, Li H, Tu Y, Du J, et al. Breast cancer cell-derived extracellular vesicles promote CD8(+) T cell exhaustion via TGF-beta type II receptor signaling. Nat Commun. 2022;13(1):4461.","journal-title":"Nat Commun"},{"key":"2627_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bcp.2019.03.031","volume":"164","author":"M Khoshakhlagh","year":"2019","unstructured":"Khoshakhlagh M, Soleimani A, Binabaj MM, Avan A, Ferns GA, Khazaei M, et al. Therapeutic potential of pharmacological TGF-\u03b2 signaling pathway inhibitors in the pathogenesis of breast cancer. Biochem Pharmacol. 2019;164:17\u201322.","journal-title":"Biochem Pharmacol"},{"issue":"0","key":"2627_CR18","first-page":"3","volume":"11","author":"Y Liang","year":"2025","unstructured":"Liang Y, Yang Q. The role of circular RNAs in glucose metabolic reprogramming: impact on cancer progression and therapeutic implications in breast cancer. J Cancer Metastasis Treat. 2025;11(0):3.","journal-title":"J Cancer Metastasis Treat"},{"key":"2627_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2021.02.004","volume":"505","author":"L Chen","year":"2021","unstructured":"Chen L, Shan G. CircRNA in cancer: Fundamental mechanism and clinical potential. Cancer Lett. 2021;505:49\u201357.","journal-title":"Cancer Lett"},{"issue":"1","key":"2627_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"WY Zhou","year":"2020","unstructured":"Zhou WY, Cai ZR, Liu J, Wang DS, Ju HQ, Xu RH. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19(1):172.","journal-title":"Mol Cancer"},{"issue":"3","key":"2627_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41418-022-00948-7","volume":"29","author":"S Misir","year":"2022","unstructured":"Misir S, Wu N, Yang BB. Specific expression and functions of circular RNAs. Cell Death Differ. 2022;29(3):481\u201391.","journal-title":"Cell Death Differ"},{"issue":"6","key":"2627_CR22","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1093\/nar\/gkw027","volume":"44","author":"WW Du","year":"2016","unstructured":"Du WW, Yang W, Liu E, Yang Z, Dhaliwal P, Yang BB. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res. 2016;44(6):2846\u201358.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2627_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-019-1046-7","volume":"18","author":"L Wang","year":"2019","unstructured":"Wang L, Long H, Zheng Q, Bo X, Xiao X, Li B. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression. Mol Cancer. 2019;18(1):119.","journal-title":"Mol Cancer"},{"issue":"34","key":"2627_CR24","doi-asserted-by":"publisher","first-page":"e2404628","DOI":"10.1002\/advs.202404628","volume":"11","author":"Z Wang","year":"2024","unstructured":"Wang Z, Li Y, Yang J, Sun Y, He Y, Wang Y, et al. CircCFL1 promotes TNBC stemness and immunoescape via deacetylation-mediated c-myc deubiquitylation to facilitate mutant TP53 transcription. Adv Sci (Weinh). 2024;11(34):e2404628.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2627_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ymthe.2021.08.026","volume":"30","author":"Y Li","year":"2022","unstructured":"Li Y, Wang Z, Su P, Liang Y, Li Z, Zhang H, et al. circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt\/beta-catenin pathway. Mol Ther. 2022;30(1):415\u201330.","journal-title":"Mol Ther"},{"issue":"1","key":"2627_CR26","doi-asserted-by":"publisher","first-page":"6876","DOI":"10.1038\/s41467-023-42571-1","volume":"14","author":"K Li","year":"2023","unstructured":"Li K, Guo J, Ming Y, Chen S, Zhang T, Ma H, et al. A circular RNA activated by TGFbeta promotes tumor metastasis through enhancing IGF2BP3-mediated PDPN mRNA stability. Nat Commun. 2023;14(1):6876.","journal-title":"Nat Commun"},{"issue":"1","key":"2627_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12943-020-01183-9","volume":"19","author":"X Zheng","year":"2020","unstructured":"Zheng X, Huang M, Xing L, Yang R, Wang X, Jiang R, et al. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer. 2020;19(1):73.","journal-title":"Mol Cancer"},{"issue":"4","key":"2627_CR28","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.7150\/ijbs.89568","volume":"20","author":"X Xin","year":"2024","unstructured":"Xin X, Cheng X, Zeng F, Xu Q, Hou L. The role of TGF-beta\/SMAD signaling in hepatocellular carcinoma: from mechanism to therapy and prognosis. Int J Biol Sci. 2024;20(4):1436\u201351.","journal-title":"Int J Biol Sci"},{"issue":"Pt 2","key":"2627_CR29","first-page":"136","volume":"86","author":"JH Lee","year":"2022","unstructured":"Lee JH, Massague J. TGF-beta in developmental and fibrogenic EMTs. Semin Cancer Biol. 2022;86(Pt 2):136\u201345.","journal-title":"Semin Cancer Biol"},{"key":"2627_CR30","doi-asserted-by":"publisher","first-page":"941123","DOI":"10.3389\/fphar.2022.941123","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhang Y, Yu F, Li X, Gao H, Li P. The circRNA-miRNA\/RBP regulatory network in myocardial infarction. Front Pharmacol. 2022;13:941123.","journal-title":"Front Pharmacol"},{"issue":"Database issue","key":"2627_CR31","doi-asserted-by":"publisher","first-page":"D301","DOI":"10.1093\/nar\/gkq1069","volume":"39","author":"KB Cook","year":"2011","unstructured":"Cook KB, Kazan H, Zuberi K, Morris Q, Hughes TR. RBPDB: a database of RNA-binding specificities. Nucleic Acids Res. 2011;39(Database issue):D301\u20138.","journal-title":"Nucleic Acids Res"},{"key":"2627_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-0716-1851-6_3","volume":"2404","author":"I Paz","year":"2022","unstructured":"Paz I, Argoetti A, Cohen N, Even N, Mandel-Gutfreund Y, RBPmap. A tool for mapping and predicting the binding sites of RNA-binding proteins considering the motif environment. Methods Mol Biol. 2022;2404:53\u201365.","journal-title":"Methods Mol Biol"},{"issue":"4","key":"2627_CR33","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","volume":"176","author":"JN Vo","year":"2019","unstructured":"Vo JN, Cieslik M, Zhang Y, Shukla S, Xiao L, Zhang Y, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869\u201381. e13.","journal-title":"Cell"},{"issue":"40","key":"2627_CR34","doi-asserted-by":"publisher","first-page":"eado8231","DOI":"10.1126\/sciadv.ado8231","volume":"10","author":"AJ Montero-Hidalgo","year":"2024","unstructured":"Montero-Hidalgo AJ, Jimenez-Vacas JM, Gomez-Gomez E, Porcel-Pastrana F, Saez-Martinez P, Perez-Gomez JM, et al. SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer. Sci Adv. 2024;10(40):eado8231.","journal-title":"Sci Adv"},{"issue":"8039","key":"2627_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/d41586-024-03708-4","volume":"635","author":"E Callaway","year":"2024","unstructured":"Callaway E. AI protein-prediction tool AlphaFold3 is now more open. Nature. 2024;635(8039):531\u20132.","journal-title":"Nature"},{"issue":"6","key":"2627_CR36","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41418-019-0458-7","volume":"27","author":"X Wang","year":"2020","unstructured":"Wang X, Xia S, Li H, Wang X, Li C, Chao Y, et al. The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis. Cell Death Differ. 2020;27(6):1747\u201364.","journal-title":"Cell Death Differ"},{"issue":"3","key":"2627_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41419-023-05734-y","volume":"14","author":"W Qiu","year":"2023","unstructured":"Qiu W, Xiao Z, Yang Y, Jiang L, Song S, Qi X, et al. USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma. Cell Death Dis. 2023;14(3):207.","journal-title":"Cell Death Dis"},{"issue":"W1","key":"2627_CR38","doi-asserted-by":"publisher","first-page":"W140","DOI":"10.1093\/nar\/gkaa275","volume":"48","author":"D Wang","year":"2020","unstructured":"Wang D, Liu D, Yuchi J, He F, Jiang Y, Cai S, et al. MusiteDeep: a deep-learning based webserver for protein post-translational modification site prediction and visualization. Nucleic Acids Res. 2020;48(W1):W140\u20136.","journal-title":"Nucleic Acids Res"},{"key":"2627_CR39","doi-asserted-by":"publisher","first-page":"780023","DOI":"10.3389\/fcell.2021.780023","volume":"9","author":"W She","year":"2021","unstructured":"She W, Shao J, Jia R. Targeting splicing factor SRSF6 for cancer therapy. Front Cell Dev Biol. 2021;9:780023.","journal-title":"Front Cell Dev Biol"},{"issue":"D1","key":"2627_CR40","doi-asserted-by":"publisher","first-page":"D1460","DOI":"10.1093\/nar\/gkae1098","volume":"53","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Liu K, Xu Z, Li B, Wu X, Fan R, et al. OncoSplicing 3.0: an updated database for identifying RBPs regulating alternative splicing events in cancers. Nucleic Acids Res. 2025;53(D1):D1460\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2627_CR41","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1053\/j.gastro.2024.02.025","volume":"167","author":"J Chen","year":"2024","unstructured":"Chen J, Feng W, Sun M, Huang W, Wang G, Chen X, et al. TGF-beta1-induced SOX18 elevation promotes hepatocellular carcinoma progression and metastasis through transcriptionally upregulating PD-L1 and CXCL12. Gastroenterology. 2024;167(2):264\u201380.","journal-title":"Gastroenterology"},{"issue":"1","key":"2627_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang T, She Y, Wu K, Gu S, Li L, et al. N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20(1):105.","journal-title":"Mol Cancer"},{"issue":"10","key":"2627_CR43","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1038\/s41418-023-01219-9","volume":"30","author":"Z Kuang","year":"2023","unstructured":"Kuang Z, Liu X, Zhang N, Dong J, Sun C, Yin M, et al. USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1. Cell Death Differ. 2023;30(10):2249\u201364.","journal-title":"Cell Death Differ"},{"issue":"1","key":"2627_CR44","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s12672-025-02867-8","volume":"16","author":"F Xu","year":"2025","unstructured":"Xu F, Lv J, Qin S, Liu L, Ren Y. Amplified TPM1 suppresses non-small cell lung cancer cells proliferation and metastasis. Discov Oncol. 2025;16(1):1098.","journal-title":"Discov Oncol"},{"issue":"1","key":"2627_CR45","first-page":"7","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2627_CR46","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/cncr.23243","volume":"112","author":"M Brown","year":"2008","unstructured":"Brown M, Tsodikov A, Bauer KR, Parise CA, Caggiano V. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999\u20132004. Cancer. 2008;112(4):737\u201347.","journal-title":"Cancer"},{"issue":"15 Pt 1","key":"2627_CR47","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Research: Official J Am Association Cancer Res. 2007;13(15 Pt 1):4429\u201334.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"key":"2627_CR48","doi-asserted-by":"crossref","unstructured":"Seoane J, Gomis RR. TGF-\u03b2 family signaling in tumor suppression and cancer progression. Cold Spring Harb Perspect Biol. 2017;9(12):a022277.","DOI":"10.1101\/cshperspect.a022277"},{"key":"2627_CR49","doi-asserted-by":"crossref","unstructured":"Hao Y, Baker D, Ten Dijke P. TGF-\u03b2-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci. 2019;20(11):2767.","DOI":"10.3390\/ijms20112767"},{"issue":"1","key":"2627_CR50","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","volume":"133","author":"D Padua","year":"2008","unstructured":"Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, et al. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell. 2008;133(1):66\u201377.","journal-title":"Cell"},{"issue":"3","key":"2627_CR51","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/1878-0261.12162","volume":"12","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Ma J, Fan Y, Wang Z, Tian R, Ji W, et al. TGF-\u03b2 transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK\/Sp1 signaling pathways. Mol Oncol. 2018;12(3):305\u201321.","journal-title":"Mol Oncol"},{"issue":"5","key":"2627_CR52","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in Oncology. Cell. 2019;179(5):1033\u201355.","journal-title":"Cell"},{"key":"2627_CR53","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cytogfr.2023.04.001","volume":"71\u201372","author":"M Turati","year":"2023","unstructured":"Turati M, Mousset A, Issa N, Turtoi A, Ronca R. TGF-beta mediated drug resistance in solid cancer. Cytokine Growth Factor Rev. 2023;71\u201372:54\u201365.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2627_CR54","doi-asserted-by":"publisher","first-page":"107611","DOI":"10.1016\/j.bioorg.2024.107611","volume":"150","author":"N Zelisko","year":"2024","unstructured":"Zelisko N, Lesyk R, Stoika R. Structure, unique biological properties, and mechanisms of action of transforming growth factor beta. Bioorg Chem. 2024;150:107611.","journal-title":"Bioorg Chem"},{"key":"2627_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.10.004","volume":"97","author":"X Wang","year":"2023","unstructured":"Wang X, Eichhorn PJA, Thiery JP. TGF-beta, EMT, and resistance to anti-cancer treatment. Semin Cancer Biol. 2023;97:1\u201311.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"2627_CR56","doi-asserted-by":"publisher","first-page":"e0119655","DOI":"10.1371\/journal.pone.0119655","volume":"10","author":"IA Krizbai","year":"2015","unstructured":"Krizbai IA, Gasparics \u00c1, Nagy\u0151szi P, Fazakas C, Moln\u00e1r J, Wilhelm I, et al. Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasation. PLoS ONE. 2015;10(3):e0119655.","journal-title":"PLoS ONE"},{"issue":"3","key":"2627_CR57","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","volume":"71","author":"X Li","year":"2018","unstructured":"Li X, Yang L, Chen LL. The biogenesis, functions, and challenges of circular RNAs. Mol Cell. 2018;71(3):428\u201342.","journal-title":"Mol Cell"},{"issue":"7818","key":"2627_CR58","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41586-020-2077-3","volume":"583","author":"EL Van Nostrand","year":"2020","unstructured":"Van Nostrand EL, Freese P, Pratt GA, Wang X, Wei X, Xiao R, et al. A large-scale binding and functional map of human RNA-binding proteins. Nature. 2020;583(7818):711\u20139.","journal-title":"Nature"},{"issue":"8","key":"2627_CR59","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41419-024-06886-1","volume":"15","author":"M Li","year":"2024","unstructured":"Li M, Fang Q, Xiao P, Yin Z, Mei G, Wang C, et al. KHSRP ameliorates acute liver failure by regulating pre-mRNA splicing through its interaction with SF3B1. Cell Death Dis. 2024;15(8):618.","journal-title":"Cell Death Dis"},{"issue":"10","key":"2627_CR60","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1093\/nar\/gkac337","volume":"50","author":"P Patel","year":"2022","unstructured":"Patel P, Buchanan CN, Zdradzinski MD, Sahoo PK, Kar AN, Lee SJ, et al. Intra-axonal translation of Khsrp mRNA slows axon regeneration by destabilizing localized mRNAs. Nucleic Acids Res. 2022;50(10):5772\u201392.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2627_CR61","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-017-0724-6","volume":"16","author":"H Yuan","year":"2017","unstructured":"Yuan H, Deng R, Zhao X, Chen R, Hou G, Zhang H, et al. SUMO1 modification of KHSRP regulates tumorigenesis by preventing the TL-G-Rich miRNA biogenesis. Mol Cancer. 2017;16(1):157.","journal-title":"Mol Cancer"},{"issue":"6","key":"2627_CR62","doi-asserted-by":"publisher","first-page":"189202","DOI":"10.1016\/j.bbcan.2024.189202","volume":"1879","author":"YC Yang","year":"2024","unstructured":"Yang YC, Ho KH, Hua KT, Chien MH. Roles of K(H)SRP in modulating gene transcription throughout cancer progression: insights from cellular studies to clinical perspectives. Biochim Biophys Acta Rev Cancer. 2024;1879(6):189202.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"15","key":"2627_CR63","doi-asserted-by":"publisher","first-page":"eadk6989","DOI":"10.1126\/sciadv.adk6989","volume":"11","author":"Y Yang","year":"2025","unstructured":"Yang Y, Wang TY, Li Q, Lu J, Ren Y, Weiner AB, et al. Androgen receptor-regulated lncRNA PRCAT71 promotes AR signaling through the interaction with KHSRP in prostate cancer. Sci Adv. 2025;11(15):eadk6989.","journal-title":"Sci Adv"},{"issue":"12","key":"2627_CR64","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.7150\/ijbs.85063","volume":"19","author":"F Long","year":"2023","unstructured":"Long F, Li L, Xie C, Ma M, Wu Z, Lu Z, et al. Intergenic CircRNA Circ_0007379 inhibits colorectal cancer progression by modulating miR-320a biogenesis in a KSRP-dependent manner. Int J Biol Sci. 2023;19(12):3781\u2013803.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2627_CR65","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13073-020-00812-8","volume":"12","author":"TLH Okholm","year":"2020","unstructured":"Okholm TLH, Sathe S, Park SS, Kamstrup AB, Rasmussen AM, Shankar A, et al. Transcriptome-wide profiles of circular RNA and RNA-binding protein interactions reveal effects on circular RNA biogenesis and cancer pathway expression. Genome Med. 2020;12(1):112.","journal-title":"Genome Med"},{"issue":"8","key":"2627_CR66","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.7150\/thno.42174","volume":"10","author":"A Huang","year":"2020","unstructured":"Huang A, Zheng H, Wu Z, Chen M, Huang Y. Circular RNA-protein interactions: functions, mechanisms, and identification. Theranostics. 2020;10(8):3503\u201317.","journal-title":"Theranostics"},{"issue":"18","key":"2627_CR67","first-page":"1402","volume":"38","author":"WW Du","year":"2017","unstructured":"Du WW, Yang W, Chen Y, Wu Z-K, Foster FS, Yang Z, et al. Foxo3 circular RNA promotes cardiac senescence by modulating multiple factors associated with stress and senescence responses. Eur Heart J. 2017;38(18):1402\u201312.","journal-title":"Eur Heart J"},{"key":"2627_CR68","doi-asserted-by":"crossref","unstructured":"Howard JM, Sanford JR. The RNAissance family: SR proteins as multifaceted regulators of gene expression. Wiley Interdiscip Rev RNA. 2015;6(1):93\u2013110.","DOI":"10.1002\/wrna.1260"},{"issue":"40","key":"2627_CR69","doi-asserted-by":"publisher","first-page":"eado8231","DOI":"10.1126\/sciadv.ado8231","volume":"10","author":"AJ Montero-Hidalgo","year":"2024","unstructured":"Montero-Hidalgo AJ, Jim\u00e9nez-Vacas JM, G\u00f3mez-G\u00f3mez E, Porcel-Pastrana F, S\u00e1ez-Mart\u00ednez P, P\u00e9rez-G\u00f3mez JM, et al. SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer. Sci Adv. 2024;10(40):eado8231.","journal-title":"Sci Adv"},{"issue":"1","key":"2627_CR70","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1136\/gutjnl-2017-314983","volume":"68","author":"L Wan","year":"2019","unstructured":"Wan L, Yu W, Shen E, Sun W, Liu Y, Kong J, et al. SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer. Gut. 2019;68(1):118\u201329.","journal-title":"Gut"},{"key":"2627_CR71","doi-asserted-by":"crossref","unstructured":"Tao L, Liu X, Jiang X, Zhang K, Wang Y, Li X, et al. USP10 as a potential therapeutic target in human cancers. Genes (Basel). 2022;13(5):831.","DOI":"10.3390\/genes13050831"},{"issue":"11","key":"2627_CR72","doi-asserted-by":"publisher","first-page":"e390","DOI":"10.1038\/emm.2017.128","volume":"49","author":"Y Jung","year":"2017","unstructured":"Jung Y, Kim HD, Yang HW, Kim HJ, Jang C-Y, Kim J. Modulating cellular balance of Rps3 mono-ubiquitination by both Hel2 E3 ligase and Ubp3 deubiquitinase regulates protein quality control. Exp Mol Med. 2017;49(11):e390.","journal-title":"Exp Mol Med"},{"issue":"2","key":"2627_CR73","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28(2):591\u2013605.","journal-title":"Cell Death Differ"},{"issue":"6","key":"2627_CR74","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.7150\/ijbs.69411","volume":"18","author":"S Han","year":"2022","unstructured":"Han S, Wang R, Zhang Y, Li X, Gan Y, Gao F, et al. The role of ubiquitination and deubiquitination in tumor invasion and metastasis. Int J Biol Sci. 2022;18(6):2292\u2013303.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2627_CR75","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41420-022-01204-0","volume":"8","author":"L Cao","year":"2022","unstructured":"Cao L, Liu X, Zheng B, Xing C, Liu J. Role of K63-linked ubiquitination in cancer. Cell Death Discov. 2022;8(1):410.","journal-title":"Cell Death Discov"},{"issue":"6","key":"2627_CR76","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1083\/jcb.201902074","volume":"218","author":"L Song","year":"2019","unstructured":"Song L, Luo Z-Q. Post-translational regulation of ubiquitin signaling. J Cell Biol. 2019;218(6):1776\u201386.","journal-title":"J Cell Biol"},{"key":"2627_CR77","doi-asserted-by":"publisher","first-page":"216703","DOI":"10.1016\/j.canlet.2024.216703","volume":"587","author":"ZY Yang","year":"2024","unstructured":"Yang ZY, Zhao C, Liu SL, Pan LJ, Zhu YD, Zhao JW, et al. NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3\/RBM14. Cancer Lett. 2024;587:216703.","journal-title":"Cancer Lett"},{"key":"2627_CR78","doi-asserted-by":"publisher","first-page":"1232146","DOI":"10.3389\/fcell.2023.1232146","volume":"11","author":"N Han","year":"2023","unstructured":"Han N, Liu Z. Targeting alternative splicing in cancer immunotherapy. Front Cell Dev Biol. 2023;11:1232146.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"2627_CR79","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/19490992.2016.1201619","volume":"6","author":"M Janco","year":"2016","unstructured":"Janco M, Bonello TT, Byun A, Coster AC, Lebhar H, Dedova I, et al. The impact of tropomyosins on actin filament assembly is isoform specific. Bioarchitecture. 2016;6(4):61\u201375.","journal-title":"Bioarchitecture"},{"key":"2627_CR80","first-page":"0252","volume":"6","author":"H Wang","year":"2023","unstructured":"Wang H, Liu J, Zhu X, Yang B, He Z, Yao X. AZGP1P2\/UBA1\/RBM15 cascade mediates the fate determinations of prostate cancer stem cells and promotes therapeutic effect of docetaxel in castration-resistant prostate cancer via TPM1 m6A modification. Res (Wash D C). 2023;6:0252.","journal-title":"Res (Wash D C)"},{"issue":"0","key":"2627_CR81","first-page":"19","volume":"10","author":"A Sabaghian","year":"2024","unstructured":"Sabaghian A, Shamsabadi S, Momeni S, Mohammadikia M, Mohebbipour K, Sanami S, et al. The role of PD-1\/PD-L1 signaling pathway in cancer pathogenesis and treatment: a systematic review. J Cancer Metastasis Treat. 2024;10(0):19.","journal-title":"J Cancer Metastasis Treat"},{"issue":"328","key":"2627_CR82","doi-asserted-by":"publisher","first-page":"328rv4","DOI":"10.1126\/scitranslmed.aad7118","volume":"8","author":"W Zou","year":"2016","unstructured":"Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci Transl Med. 2016;8(328):328rv4.","journal-title":"Sci Transl Med"},{"issue":"17","key":"2627_CR83","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","volume":"373","author":"H Borghaei","year":"2015","unstructured":"Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015;373(17):1627\u201339.","journal-title":"N Engl J Med"},{"issue":"19","key":"2627_CR84","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","volume":"373","author":"RJ Motzer","year":"2015","unstructured":"Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, et al. Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl J Med. 2015;373(19):1803\u201313.","journal-title":"N Engl J Med"},{"issue":"1","key":"2627_CR85","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-022-01242-2","volume":"15","author":"M Wu","year":"2022","unstructured":"Wu M, Huang Q, Xie Y, Wu X, Ma H, Zhang Y, et al. Improvement of the anticancer efficacy of PD-1\/PD-L1 blockade via combination therapy and PD-L1 regulation. J Hematol Oncol. 2022;15(1):24.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2627_CR86","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s40425-019-0805-8","volume":"7","author":"S Das","year":"2019","unstructured":"Das S, Johnson DB. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors. J Immunother Cancer. 2019;7(1):306.","journal-title":"J Immunother Cancer"},{"issue":"7693","key":"2627_CR87","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"5","key":"2627_CR88","doi-asserted-by":"publisher","first-page":"e1308616","DOI":"10.1080\/2162402X.2017.1308616","volume":"6","author":"M Terabe","year":"2017","unstructured":"Terabe M, Robertson FC, Clark K, De Ravin E, Bloom A, Venzon DJ, et al. Blockade of only TGF-\u03b2 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy. Oncoimmunology. 2017;6(5):e1308616.","journal-title":"Oncoimmunology"},{"issue":"1","key":"2627_CR89","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-022-01307-2","volume":"15","author":"L Xu","year":"2022","unstructured":"Xu L, Zou C, Zhang S, Chu TSM, Zhang Y, Chen W, et al. Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors. J Hematol Oncol. 2022;15(1):87.","journal-title":"J Hematol Oncol"},{"issue":"15","key":"2627_CR90","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1158\/0008-5472.CAN-21-0633","volume":"81","author":"N Cousin","year":"2021","unstructured":"Cousin N, Cap S, Dihr M, Tacconi C, Detmar M, Dieterich LC. Lymphatic PD-L1 expression restricts tumor-specific CD8\u2009+\u2009T-cell Responses. Cancer Res. 2021;81(15):4133\u201344.","journal-title":"Cancer Res"},{"key":"2627_CR91","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2019.10.013","volume":"468","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Zhan H. Communication between EMT and PD-L1 signaling: new insights into tumor immune evasion. Cancer Lett. 2020;468:72\u201381.","journal-title":"Cancer Lett"},{"key":"2627_CR92","doi-asserted-by":"crossref","unstructured":"Wang X, Yang X, Xing L, Chen H, Xie F, Wang B, et al. CircLRBA promotes epithelial-mesenchymal transition, immune evasion, chemoimmunotherapy resistance and metastasis through stabilizing twist1. Adv Sci (Weinh). 2025;12(48):e08918.","DOI":"10.1002\/advs.202508918"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02627-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02627-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02627-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T02:02:59Z","timestamp":1776391379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02627-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2627"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02627-4","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental procedures conducted in this study received approval from the Ethical Committee of Shandong University. Tissue samples were obtained from patients admitted to Qilu Hospital at the time of surgery and promptly stored at -80\u00a0\u00b0C. Written informed consent was obtained from all participating patients prior to their inclusion in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final version of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}